Acceleron raises $120M in follow-on

Acceleron Pharma Inc. (NASDAQ:XLRN) raised $120 million through the sale of 2.4 million shares at $50 in a bumped-up follow-on underwritten by Citigroup; Leerink; Piper Jaffray; and JMP Securities. On Tuesday, Acceleron said it planned to raise up to $100 million through the sale of 2 million shares. The company first proposed to raise up to $115 million in the offering earlier this month. Acceleron was down $5.69 (10%) to $51.01 on Thursday. ...